Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas (Q48279348)
Jump to navigation
Jump to search
scientific article published on 22 November 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas |
scientific article published on 22 November 2012 |
Statements
1 reference
Bevacizumab alone or in combination with irinotecan in recurrent WHO grade II and grade III gliomas (English)
1 reference
Michael Weller
1 reference
Wolfgang Wick
1 reference
Benedikt Wiestler
1 reference
Antje Wick
1 reference
Caroline Happold
1 reference
Katharina Seystahl
1 reference
Thomas Hundsberger
1 reference
22 November 2012
1 reference
1 reference
69
1 reference
2
1 reference
95-101
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference